Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

eBioMedicine, 2023
Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis

Feng X., Muller D., Zahed H. et al.

Olink Target 96OncologyPatient StratificationBlood

Frontiers in Molecular Neuroscience, 2023
Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder

Bao X., Chen B., Liu J. et al.

Olink Target 96NeurologyPatient StratificationPlasma

American Journal of Physiology-Heart and Circulatory Physiology, 2023
Characterization of a robust mouse model of heart failure with preserved ejection fraction

Matsiukevich D., Kovacs A., Li T. et al.

Olink Target 96 MouseCVDPathophysiologySerum

Scientific Reports, 2023
Metagenomic sequencing of human cardiac tissue reveals Microbial RNA which correlates with Toll-like receptor-associated inflammation in patients with heart disease

Sandstedt J., Vukusic K., Dellgren G. et al.

Olink Target 96CVDPathophysiologyPlasma

Scientific Reports, 2023
Causal relationships between serum matrix metalloproteinases and estrogen receptor-negative breast cancer: a bidirectional mendelian randomization study

Zhao Z., Cao Q., Zhu M. et al.

Olink Target 96OncologyPathophysiologyPlasma

Microorganisms, 2023
Systemic Inflammatory Molecules Are Associated with Advanced Fibrosis in Patients from Brazil Infected with Hepatitis Delta Virus Genotype 3 (HDV-3)

Souza Campos M., Villalobos-Salcedo J., Vieira Dallacqua D. et al.

Olink Target 96Infectious DiseasesHepatologyPathophysiologyPatient StratificationSerum

Neurobiology of Disease, 2023
Uncovering a neurological protein signature for severe COVID-19

El-Agnaf O., Bensmail I., Al-Nesf M. et al.

Olink Target 96NeurologyInfectious DiseasesPathophysiologyPatient StratificationPlasma

BMC Medicine, 2023
Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis

Walker J., Joy A., Vos L. et al.

Olink Target 96OncologyMetabolic DiseasesPathophysiologyPlasma

Clinical Rheumatology, 2023
Plasma proteomic profiling reveals KRT19 could be a potential biomarker in patients with anti-MDA5+ dermatomyositis

Zhang P., Li M., Zhang Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

International Journal of Molecular Sciences, 2023
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Clavero E., Sanchez-Maldonado J., Macauda A. et al.

Olink Target 96OncologyPathophysiologyPlasmaSerum

Frontiers in Immunology, 2023
Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Li M., Zhang Y., Zhang W. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Brain, Behavior, and Immunity, 2023
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity

Eren F., Schwieler L., Orhan F. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF

JACC: Heart Failure, 2023
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF

Michaëlsson E., Lund L., Hage C. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Nature Communications, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetes

Slieker R., Donnelly L., Akalestou E. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

International Journal of Molecular Sciences, 2023
Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

Ehtewish H., Mesleh A., Ponirakis G. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Annals of Hematology, 2023
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

Geelen I., Gullaksen S., Ilander M. et al.

Olink Target 96OncologyPathophysiology

American Journal of Respiratory Cell and Molecular Biology, 2023
WNT9A Affects Late-Onset Acute Respiratory Distress Syndrome and 28-Day Survival: Evidence from a Three-Step Multiomics Study

Chen J., Tang J., Nie M. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

Nature Communications, 2023
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19

Radzikowska U., Eljaszewicz A., Tan G. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyCell Culture Supernatant

Scandinavian Journal of Rheumatology, 2023
Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures

Ferreira M., Kobayashi M., Costa R. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Journal of Affective Disorders, 2023
Dissecting the causal association between inflammation and post-traumatic stress disorder: A bidirectional Mendelian randomization study

Zuo C., Zhuang Z., Yang P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

2996 publications